EPNS Congress 2027
6 April 2027 – 10 April 2027
Centre de Convencions Internacional de Barcelona, Barcelona, Spain
The 17th Congress of the European Paediatric Neurology Society (EPNS) takes place from 6 to 10 April 2027 at the CCIB – Barcelona International Convention Centre, under the theme "From technological complexity to patient centered care". Hosted locally by SENEP, the Spanish Society of Paediatric Neurology, and organised by Intercongress GmbH, it brings together paediatric neurologists, neuroscientists and allied health professionals for plenary and parallel sessions, early morning teaching sessions, ePoster presentations and industry symposia, with highlight topics including artificial intelligence, rare diseases, neurodevelopmental disorders, advanced therapies and neurogenetics.
79 sessions · 100 speakers
Organiser (1)
European Paediatric Neurology Society
Sponsors (9)
Santhera · Italfarmaco · Danone · Slentyo · Orchard Therapeutics · Sarepta Therapeutics Inc. · Zevra · Ultragenyx · Vitaflo
Agenda
- Welcome 6 April 2027
- Introductory lecture: Brain Metabolism in Childhood: Mechanisms and Clinical Implications 6 April 2027
- Session 1: Cognition, Behaviour and Metabolism 6 April 2027
- Session 2: Epilepsy and Metabolism 6 April 2027
- Session 3: Movement disorders and Metabolism 6 April 2027
- Session 4: Metabolic treatments for brain disorders beyond IEM 6 April 2027
- Conclusions and Wrap-up 6 April 2027
- Opening Ceremony, Aicardi Award Lecture 6 April 2027 · Hall 116
- Mimics, Movies and Mistakes: A Video Journey Through Paroxysmal Events 7 April 2027 · Hall 112
- How to interpret a genetic report? 7 April 2027 · Hall 113
- War & the Brain: Pediatric Brain Health in Conflict Scenarios 7 April 2027 · Hall 116
- Bridging Neurology and Palliative Care: Managing Pain in Children with Complex Neurological Disease 7 April 2027 · Hall 114
- ePoster exhibition 7 April 2027 · Area 1
- The continuum of Encephalitis: Infection, inmunity, and post-infectious Autoinmunity 7 April 2027 · Hall 116
- Neurodevelopmental disorders 7 April 2027 · Hall 114
- Epilepsy I 7 April 2027 · Hall 113
- Neuroinflammatory diseases I 7 April 2027 · Hall 112
- Neuromuscular disorders I 7 April 2027 · Hall 116
- Moderated CAT.2 ePoster session 7 April 2027 · Area 1
- Industry Symposium – Sarepta 7 April 2027 · Hall 113
- Industry Symposium – Italfarmaco 7 April 2027 · Hall 116
- Industry Symposium – Orchard 7 April 2027 · Hall 114
- Industry Symposium – UCB 7 April 2027 · Hall 112
- Neurometabolic disorders 7 April 2027 · Hall 116
- Cerebrovascular and neurocritical care 7 April 2027 · Hall 113
- Neuromuscular disorders II 7 April 2027 · Hall 112
- Neurogenetic disorders I 7 April 2027 · Hall 114
- How will screening strategies change the future of child neurology? 7 April 2027 · Hall 116
- Industry Symposium – Santhera 7 April 2027 · Hall 113
- Industry Symposium – Biogen 7 April 2027 · Hall 112
- Industry Symposium – Danone 7 April 2027 · Hall 116
- Industry Symposium – Ultragenyx 7 April 2027 · Hall 114
- Clinical approach to a child with a first acquired demyelinating event 8 April 2027 · Hall 114
- Individualizing treatment in neonatal and childhood epilepsies 8 April 2027 · Hall 113
- EMG: a basic guide for child neurologists 8 April 2027 · Hall 116
- ePoster exhibition 8 April 2027 · Area 1
- Let’s read EEGs together 8 April 2027 · Hall 112
- AI, Machine Learning and Epilepsies in Children 8 April 2027 · Hall 116
- Neuroinflammatory diseases II 8 April 2027 · Hall 114
- Movement disorders I 8 April 2027 · Hall 116
- Epilepsy II 8 April 2027 · Hall 112
- Foetal and neonatal neurology 8 April 2027 · Hall 113
- Moderated CAT.2 ePoster session 8 April 2027 · Area 1
- Industry Symposium – Neurim 8 April 2027 · Hall 114
- Industry Symposium – Novartis 8 April 2027 · Hall 116
- Industry Symposium – Biogen 8 April 2027 · Hall 112
- Industry Symposium – F. Hoffmann-La Roche 8 April 2027 · Hall 113
- Moderated CAT.1 ePoster Session 3 8 April 2027 · Hall 113
- Moderated CAT.1 ePoster Session 4 8 April 2027 · Hall 114
- Moderated CAT.1 ePoster Session 1 8 April 2027 · Hall 116
- Moderated CAT.1 ePoster Session 2 8 April 2027 · Hall 112
- YEPNS Session 8 April 2027 · Hall 116
- Industry Symposium – Zevra Therapeutics 8 April 2027 · Hall 113
- Industry Symposium – UCB 8 April 2027 · Hall 112
- Past, present and future of neuromodulation therapies in paediatric neurology 8 April 2027 · Hall 116
- Genetical immunological mimickers of autoimmune encephalitis 9 April 2027 · Hall 112
- New biomarkers in Paediatric Neurology 9 April 2027 · Hall 114
- ePoster exhibition 9 April 2027 · Area 1
- Rethinking cerebral palsy diagnosis in the era of genomics 9 April 2027 · Hall 113
- Time is Brain: Building a Stroke-Ready Paediatric Neurology Team 9 April 2027 · Hall 116
- The journey of an orphan drug 9 April 2027 · Hall 116
- Movement disorders II 9 April 2027 · Hall 113
- Neurogenetic disorders II 9 April 2027 · Hall 114
- Sleep disorders 9 April 2027 · Hall 116
- White matter diseases 9 April 2027 · Hall 112
- Moderated CAT.2 ePoster session 9 April 2027 · Area 1
- Industry Symposium – Immedica 9 April 2027 · Hall 113
- Industry Symposium – Novartis 9 April 2027 · Hall 116
- Industry Symposium – Acadia 9 April 2027 · Hall 114
- Industry Symposium – Biomarin 9 April 2027 · Hall 112
- Pediatric neurooncology and acquired brain injury (Neurocutaneous syndromes) 9 April 2027 · Hall 112
- Neurodevelopmental disorders II 9 April 2027 · Hall 116
- Cerebral palsy and miscellaneous 9 April 2027 · Hall 114
- Infectious diseases of the CNS 9 April 2027 · Hall 113
- From Genes to Precision Therapies 9 April 2027 · Hall 116
- EPNS General Meeting 10 April 2027 · Hall 116
- From first signal to first year: what's new in fetal and neonatal brain care (EPNS Academy of Paediatric Neurology) 10 April 2027 · Hall 116
- Highlights in Paediatric Neurology 10 April 2027 · Hall 116
- Awards and Closing 10 April 2027 · Hall 116